Jingang Group

Jingang Group, primarily operating through its subsidiary Dalian Jingang Pharmaceutical, is a prominent Chinese pharmaceutical conglomerate focused on the development, manufacturing, and commercialization of traditional and modern medicines. The company is best known for its oncology portfolio, particularly the production of Cinobufacini (Huachansu), a traditional Chinese medicine derivative widely used in the treatment of various cancers. Beyond oncology, Jingang Group maintains a diverse product line covering cardiovascular, respiratory, and anti-infective therapeutic areas. The group operates large-scale GMP-certified manufacturing facilities and has established a significant presence in the domestic Chinese healthcare market through its integrated health industry approach.